- Previous Close
70.35 - Open
70.35 - Bid 69.91 x --
- Ask --
- Day's Range
69.00 - 70.72 - 52 Week Range
44.10 - 91.00 - Volume
1,660 - Avg. Volume
3,533 - Market Cap (intraday)
1.47B - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
103.94 - EPS (TTM)
0.68 - Earnings Date Feb 12, 2025 - Feb 17, 2025
- Forward Dividend & Yield 0.50 (0.67%)
- Ex-Dividend Date Sep 18, 2023
- 1y Target Est
--
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE lasik, touch free laser, lasik eye surgery, epilasik, intralase, supracor, robotic femto laser cataract surgery, phacoemulsification, paediatric eye care and squint surgery, and micro incision cataract surgery treatments. It also provides epizyoptix, special kertometer, and synaptophore; SICS, Phaco, MICS, LRCS, SFLOL, and SF IOL cataract surgery; corneal patchgraft, scleral repair, scrapping + AMG, suture, tatooing, tear suturing, and drop removal; pertygium, C3R, penetrating keratoplasty, TPK and DALK, and DASE; membrane peeling and endolaser; ERM removal, silicon oil and removal, vitrectomy lavage, FGE and C3F8, LPFC and CYCLO CRYO, and scleral buckling and belt buckle; ivta, avastin, razumab, ozurdex, zybev, eyelea, lucentis, and accentrix injections; trabeculectomy; and enucleation, evisceration, DCR and DCT, PTOSIS, and lateral tarsorrhaphy services. In addition, the company offers services in the areas of refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, uvea and ocular inflammation, zyoptix ultimate, and binocular vision. Further, it operates an eye bank, optical showroom, pharmacy, and research trust; and offers a Bachelor of Science degree in optometry, various optical fellowship courses, and a DNB program. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
www.lotuseye.org336
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: LOTUSEYE.BO
View MorePerformance Overview: LOTUSEYE.BO
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LOTUSEYE.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LOTUSEYE.BO
View MoreValuation Measures
Market Cap
1.46B
Enterprise Value
1.45B
Trailing P/E
103.46
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.05
Price/Book (mrq)
2.43
Enterprise Value/Revenue
3.03
Enterprise Value/EBITDA
22.41
Financial Highlights
Profitability and Income Statement
Profit Margin
4.44%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
485.33M
Net Income Avi to Common (ttm)
21.54M
Diluted EPS (ttm)
0.68
Balance Sheet and Cash Flow
Total Cash (mrq)
69.3M
Total Debt/Equity (mrq)
1.87%
Levered Free Cash Flow (ttm)
--